Correlation Between Evolus and Regencell Bioscience
Can any of the company-specific risk be diversified away by investing in both Evolus and Regencell Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evolus and Regencell Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evolus Inc and Regencell Bioscience Holdings, you can compare the effects of market volatilities on Evolus and Regencell Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evolus with a short position of Regencell Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evolus and Regencell Bioscience.
Diversification Opportunities for Evolus and Regencell Bioscience
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Evolus and Regencell is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Evolus Inc and Regencell Bioscience Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regencell Bioscience and Evolus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evolus Inc are associated (or correlated) with Regencell Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regencell Bioscience has no effect on the direction of Evolus i.e., Evolus and Regencell Bioscience go up and down completely randomly.
Pair Corralation between Evolus and Regencell Bioscience
Given the investment horizon of 90 days Evolus is expected to generate 3.28 times less return on investment than Regencell Bioscience. But when comparing it to its historical volatility, Evolus Inc is 5.61 times less risky than Regencell Bioscience. It trades about 0.04 of its potential returns per unit of risk. Regencell Bioscience Holdings is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 2,960 in Regencell Bioscience Holdings on August 27, 2024 and sell it today you would lose (2,369) from holding Regencell Bioscience Holdings or give up 80.03% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 94.95% |
| Values | Daily Returns |
Evolus Inc vs. Regencell Bioscience Holdings
Performance |
| Timeline |
| Evolus Inc |
| Regencell Bioscience |
Evolus and Regencell Bioscience Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evolus and Regencell Bioscience
The main advantage of trading using opposite Evolus and Regencell Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evolus position performs unexpectedly, Regencell Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regencell Bioscience will offset losses from the drop in Regencell Bioscience's long position.| Evolus vs. Collegium Pharmaceutical | Evolus vs. Phibro Animal Health | Evolus vs. ANI Pharmaceuticals | Evolus vs. Procaps Group SA |
| Regencell Bioscience vs. Delta 9 Cannabis | Regencell Bioscience vs. City View Green | Regencell Bioscience vs. Benchmark Botanics | Regencell Bioscience vs. Speakeasy Cannabis Club |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |